Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
CureVac has today suffered a defeat in its dispute against BioNTech over mRNA patents, after the German Federal Patent Court nullified the German part of an important patent. The decision will affect
In the extensive dispute over mRNA patents, CureVac has achieved a victory at the European Patent Office. The Opposition Division upheld two important patents in amended form. Parallel infringement
Arbutus' lawsuit against the mRNA vaccine Spikevax involves 15 Moderna companies. Now, the local division The Hague has declared itself competent to hear the lawsuits against European companies based
FRANKFURT, Nov 21 (Reuters) - The European Patent Office declared a contested mRNA patent owned by Moderna (MRNA.O) invalid, the office said on Tuesday, handing a win to BioNTech (22UAy.DE) and its
mRESVIA vaccines (among others) are infringing their mRNA-related patents in 30 different countries. The companies have filed lawsuits in the Federal Court of Canada, the Tokyo District Court
total 1 pages, 5 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
